Subscribe to Money Morning get daily headlines subscribe now! Money Morning Private Briefing today's private briefing Access Your Profit Alerts

Imprimis Phar Cmn (NASDAQ: IMMY)

$3.40 USD -$0.10 (-2.86%)
Last Price $3.4
Net Change $-0.1 (-2.86%)
Bid $0
Ask Price $0
Open Price $3.51
Previous Close Price $3.5
High Price $3.58
Low Price $3.34
Number of Trades 244
Volume 78,108
Fifty Two Week High $4.69 (2017-03-29)
Fifty Two Week Low $1.65 (2016-12-21)
Average Daily Volume 196,796
Share Outstanding 20,070 Shares
Total Dividend Payout 0/yr
Dividend Yield 0%
1st Quarter Earnings $ ()
2nd Quarter Earnings $ ()
3nd Quarter Earnings $ ()
4th Quarter Earnings $ ()
PE Ratio $0
EPS Growth $42.67
Recent Earnings $
Annual EPS $-1.34
Last Quarter EPS $
Market Capitalization $0.07B
Insider Shareholders % 0.1255%
Annual Revenue $0B
No. Shares Outstanding 20,070
Inst. Shareholder % 17.13%
Annual Net Income $-0.02B
TTM Net Profit Margin $-90.49
1-Year Return -12.06%
3-Year Return -40.48%
5-Year Return 16.67%
5-Year Revenue Growth 0%
5-Year Earnings Growth 0%
5-Year Dividend Growth 0%
Annual Dividend $0
Annual Dividend Yield 0%
Change in EPS YTD 42.669998%
Dividends per Share $
Stock Split Ratio 1-5
Beta 0.4
Imprimis Pharmaceuticals, Inc. is a pharmaceutical company focused on its proprietary ophthalmology and urology drug formulations. Imprimis recently launched its urology business, which includes a patented formulation to address patients suffering from interstitial cystitis.